A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma.

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1111/pcmr.12394

2 Figures and Tables

Topics

  • Presentations referencing similar topics